A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
Completed · Phase 2 · Has a placebo group
Conditions studied: Hepatitis C, Chronic
In brief
The purpose of this study is to determine if IDN-6556, when given orally, is safe and effective in patients with chronic hepatitis C virus infection.
Key facts
- Study ID
- NCT00088140
- Run by
- Conatus Pharmaceuticals Inc.
- People needed
- 204
- Starts
- 2004-07-01
- Expected to finish
- 2005-10-01
- Last updated by the study team
- 2012-08-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Chronic hepatitis C infection
- Unsuccessful prior HCV treatment
- Liver impairment (either AST or ALT 1.5-10.0 x ULN)
- Alpha-fetoprotein <= 50 ng/mL
- Adequate hematologic parameters
You may not qualify if…
- Decompensated or severe liver disease
- Hepatocellular carcinoma
- HIV infection
- Co-infection with hepatitis B virus (HBV)
- Renal impairment
- Pancreatitis
- Use of illicit or drugs of abuse
- History of alcohol abuse
- Presence of clinically significant cardiac arrhythmias
- If female, pregnant or lactating
Where it is running
- Mayo Clinic Hospital — Phoenix, Arizona, United States
- Scripps Clinic — La Jolla, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of California, San Francisco — San Francisco, California, United States
- University of Miami — Miami, Florida, United States
- Indiana University School of Medicine — Indianapolis, Indiana, United States
- Beth Israel Deaconness Medical Center — Boston, Massachusetts, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- The Mayo Clinic — Rochester, Minnesota, United States
- Mt. Sinai School of Medicine — New York, New York, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- Duke University Medical Center — Durham, North Carolina, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- Metrohealth Medical Center — Cleveland, Ohio, United States
- Medical College of Virginia — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.